UNSPSC 51285306: Furalazine

This classification denotes an anti-infective agent with the molecular formula C9H7N5O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2133JVQ6VE, chemically known as 1,2,4-triazin-3-amine, 6-(2-(5-nitro-2-furanyl)ethenyl)- (9ci) but more generally known as furalazine, which bears US NIH Compound Identifier 6436102. European Medicines Agency schedules Furalazine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07830MIG. The term FURALAZINE is an International Non-Proprietary Name.

UNSPSC 51285306 Furalazine is a Commodity code, but the recent state and local opportunities posted under it do not reflect furalazine procurement — instead, the code shows activity related to pharmaceutical supply contracting for unrelated drugs and medical devices, chiefly naloxone and safe drug deactivation systems. State and local health agencies and counties use this code nominally to solicit pharmaceutical warehouse orders and community health supplies through cooperative purchasing agreements and competitive bids. The issuing bodies include state departments of public health, county governments, and county-managed community health facilities, typically procuring on behalf of emergency response, public health, or substance-abuse intervention programs.

Geographic activity appears concentrated in the Midwest and Southeast, with the Illinois Department of Public Health and Seminole County, Florida posting recent opportunities. The Illinois Department of Public Health awarded a $2,999,999.11 piggyback pharmaceutical warehouse contract to Chartwell Rx LLC through the MMCAP Infuse consortium on August 28, 2026, under an Invitation for Bid process for Doxycycline Hyclate and Ciprofloxacin Hydrochloride with a 12-month initial term and two one-year renewal options. Seminole County, Florida posted an IFB on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building; the bid response deadline was July 26, 2023, with a two-year initial term and one-year renewal option. Neither opportunity required set-aside or preference designations. The mismatch between the code's nominal scope (furalazine, a veterinary antibiotic) and the actual solicitations suggests the code may be misapplied to pharmaceutical supply contracting more broadly.